View ValuationSobute New Materials 향후 성장Future 기준 점검 4/6Sobute New Materials (는) 각각 연간 28.3% 및 16.3% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 27.8% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 5.8% 로 예상됩니다.핵심 정보28.3%이익 성장률27.84%EPS 성장률Chemicals 이익 성장30.6%매출 성장률16.3%향후 자기자본이익률5.79%애널리스트 커버리지Low마지막 업데이트23 Apr 2026최근 향후 성장 업데이트Price Target Changed • Apr 18Price target decreased by 12% to CN¥10.83Down from CN¥12.31, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥10.61. Stock is up 47% over the past year. The company is forecast to post earnings per share of CN¥0.38 for next year compared to CN¥0.29 last year.Major Estimate Revision • May 05Consensus EPS estimates fall by 15%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥3.63b to CN¥3.77b. EPS estimate fell from CN¥0.408 to CN¥0.347 per share. Net income forecast to grow 56% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥9.67 unchanged from last update. Share price rose 10.0% to CN¥8.16 over the past week.Price Target Changed • Sep 03Price target decreased by 9.6% to CN¥8.91Down from CN¥9.86, the current price target is an average from 4 analysts. New target price is 27% above last closing price of CN¥7.04. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥0.36 for next year compared to CN¥0.38 last year.Major Estimate Revision • Sep 02Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.71b to CN¥3.54b. EPS estimate also fell from CN¥0.462 per share to CN¥0.392 per share. Net income forecast to grow 59% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥9.86 to CN¥9.24. Share price rose 2.8% to CN¥7.36 over the past week.분석 기사 • Aug 28Earnings Release: Here's Why Analysts Cut Their Sobute New Materials Co., Ltd (SHSE:603916) Price Target To CN¥9.24As you might know, Sobute New Materials Co., Ltd ( SHSE:603916 ) recently reported its quarterly numbers. Results look...분석 기사 • Apr 29Earnings Update: Sobute New Materials Co., Ltd (SHSE:603916) Just Reported And Analysts Are Trimming Their ForecastsShareholders might have noticed that Sobute New Materials Co., Ltd ( SHSE:603916 ) filed its first-quarter result this...모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥14.46, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 4.5% over the past three years.Price Target Changed • Apr 18Price target decreased by 12% to CN¥10.83Down from CN¥12.31, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥10.61. Stock is up 47% over the past year. The company is forecast to post earnings per share of CN¥0.38 for next year compared to CN¥0.29 last year.Reported Earnings • Apr 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.29 (up from CN¥0.23 in FY 2024). Revenue: CN¥3.56b (flat on FY 2024). Net income: CN¥121.0m (up 26% from FY 2024). Profit margin: 3.4% (up from 2.7% in FY 2024). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.공시 • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu ChinaNew Risk • Apr 16New major risk - Revenue and earnings growthEarnings have declined by 38% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 38% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.6% average weekly change).공시 • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.6% average weekly change).Buy Or Sell Opportunity • Jan 30Now 26% undervaluedOver the last 90 days, the stock has risen 28% to CN¥13.20. The fair value is estimated to be CN¥17.75, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 48%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 130% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥12.48, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.06 per share.Valuation Update With 7 Day Price Move • Jan 09Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥11.25, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥16.84 per share.공시 • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.07 (vs CN¥0.06 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.07 (up from CN¥0.06 in 3Q 2024). Revenue: CN¥904.0m (flat on 3Q 2024). Net income: CN¥30.9m (up 22% from 3Q 2024). Profit margin: 3.4% (up from 2.8% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.Board Change • Oct 11Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025New Risk • Jul 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (2.7% net profit margin).Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥11.56, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 41% over the past three years.공시 • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025Declared Dividend • Jun 07Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 33% lower than last year. Ex-date: 12th June 2025 Payment date: 12th June 2025 Dividend yield will be 1.1%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (12% cash payout ratio). The dividend has decreased over the past 76 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 146% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Major Estimate Revision • May 05Consensus EPS estimates fall by 15%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥3.63b to CN¥3.77b. EPS estimate fell from CN¥0.408 to CN¥0.347 per share. Net income forecast to grow 56% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥9.67 unchanged from last update. Share price rose 10.0% to CN¥8.16 over the past week.Reported Earnings • Apr 29Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: CN¥0.23 (down from CN¥0.38 in FY 2023). Revenue: CN¥3.56b (flat on FY 2023). Net income: CN¥95.9m (down 40% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 35%. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.공시 • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.공시 • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025공시 • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.분석 기사 • Sep 26Sobute New Materials Co., Ltd's (SHSE:603916) Shares Not Telling The Full StoryIt's not a stretch to say that Sobute New Materials Co., Ltd's ( SHSE:603916 ) price-to-earnings (or "P/E") ratio of...Price Target Changed • Sep 03Price target decreased by 9.6% to CN¥8.91Down from CN¥9.86, the current price target is an average from 4 analysts. New target price is 27% above last closing price of CN¥7.04. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥0.36 for next year compared to CN¥0.38 last year.Major Estimate Revision • Sep 02Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.71b to CN¥3.54b. EPS estimate also fell from CN¥0.462 per share to CN¥0.392 per share. Net income forecast to grow 59% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥9.86 to CN¥9.24. Share price rose 2.8% to CN¥7.36 over the past week.분석 기사 • Aug 28Earnings Release: Here's Why Analysts Cut Their Sobute New Materials Co., Ltd (SHSE:603916) Price Target To CN¥9.24As you might know, Sobute New Materials Co., Ltd ( SHSE:603916 ) recently reported its quarterly numbers. Results look...Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.분석 기사 • Aug 14Sobute New Materials (SHSE:603916) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...공시 • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024분석 기사 • Jun 19Sobute New Materials Co., Ltd (SHSE:603916) Stock's 25% Dive Might Signal An Opportunity But It Requires Some ScrutinySobute New Materials Co., Ltd ( SHSE:603916 ) shares have had a horrible month, losing 25% after a relatively good...Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.분석 기사 • Apr 29Earnings Update: Sobute New Materials Co., Ltd (SHSE:603916) Just Reported And Analysts Are Trimming Their ForecastsShareholders might have noticed that Sobute New Materials Co., Ltd ( SHSE:603916 ) filed its first-quarter result this...공시 • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu ChinaReported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.40, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 68% over the past three years.공시 • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).공시 • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024Major Estimate Revision • Nov 02Consensus EPS estimates fall by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥3.71b to CN¥3.58b. EPS estimate also fell from CN¥0.63 per share to CN¥0.562 per share. Net income forecast to grow 60% next year vs 66% growth forecast for Chemicals industry in China. Consensus price target down from CN¥16.58 to CN¥15.16. Share price rose 4.2% to CN¥11.75 over the past week.Price Target Changed • Oct 29Price target decreased by 8.5% to CN¥15.16Down from CN¥16.58, the current price target is an average from 5 analysts. New target price is 29% above last closing price of CN¥11.74. Stock is down 22% over the past year. The company is forecast to post earnings per share of CN¥0.56 for next year compared to CN¥0.69 last year.Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.Major Estimate Revision • Apr 27Consensus revenue estimates decrease by 10%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.71b to CN¥4.23b. EPS estimate unchanged from CN¥1.14 per share at last update. Chemicals industry in China expected to see average net income growth of 43% next year. Consensus price target of CN¥20.10 unchanged from last update. Share price fell 6.0% to CN¥14.45 over the past week.Reported Earnings • Apr 23Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.Major Estimate Revision • Apr 21Consensus revenue estimates decrease by 10%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.71b to CN¥4.23b. EPS estimate unchanged from CN¥1.05 per share at last update. Chemicals industry in China expected to see average net income growth of 38% next year. Consensus price target of CN¥20.10 unchanged from last update. Share price fell 7.1% to CN¥15.02 over the past week.Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 61% over the past three years.Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.Price Target Changed • Nov 05Price target decreased to CN¥21.44Down from CN¥24.74, the current price target is an average from 3 analysts. New target price is 36% above last closing price of CN¥15.78. Stock is down 7.6% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥1.27 last year.Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 10% per year.Major Estimate Revision • Sep 02Consensus revenue estimates fall by 10%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥5.28b to CN¥4.74b. EPS estimate fell from CN¥1.51 to CN¥1.36 per share. Net income forecast to grow 33% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥28.95 to CN¥25.89. Share price fell 7.0% to CN¥18.57 over the past week.Price Target Changed • Aug 30Price target decreased to CN¥25.89Down from CN¥28.95, the current price target is an average from 5 analysts. New target price is 33% above last closing price of CN¥19.45. Stock is down 13% over the past year. The company is forecast to post earnings per share of CN¥1.41 for next year compared to CN¥1.27 last year.Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • May 01Price target decreased to CN¥28.95Down from CN¥31.60, the current price target is an average from 6 analysts. New target price is 28% above last closing price of CN¥22.66. Stock is down 9.8% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.27 last year.Reported Earnings • Apr 30First quarter 2022 earnings: EPS misses analyst expectationsFirst quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.5%. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.Major Estimate Revision • Apr 27Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥5.64b to CN¥5.37b. EPS estimate also fell from CN¥1.71 per share to CN¥1.53 per share. Net income forecast to grow 21% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target down from CN¥31.60 to CN¥30.75. Share price fell 3.7% to CN¥21.26 over the past week.Reported Earnings • Apr 17Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.5%. Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 23% per year.Price Target Changed • Jan 06Price target increased to CN¥31.60Up from CN¥26.65, the current price target is an average from 5 analysts. New target price is 19% above last closing price of CN¥26.46. Stock is up 23% over the past year. The company is forecast to post earnings per share of CN¥1.32 for next year compared to CN¥1.16 last year.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 181% over the past three years.Price Target Changed • Dec 04Price target decreased to CN¥24.31Down from CN¥26.65, the current price target is an average from 5 analysts. New target price is 19% above last closing price of CN¥20.45. Stock is down 3.5% over the past year. The company is forecast to post earnings per share of CN¥1.32 for next year compared to CN¥1.16 last year.Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 136% over the past three years.Price Target Changed • Nov 01Price target decreased to CN¥26.65Down from CN¥29.61, the current price target is an average from 6 analysts. New target price is 54% above last closing price of CN¥17.32. Stock is down 18% over the past year. The company is forecast to post earnings per share of CN¥1.35 for next year compared to CN¥1.16 last year.Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 20% per year.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 23% per year.Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year whereas the company’s share price has increased by 24% per year.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥30.84, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 127% over the past three years.공시 • Mar 04Sobute New Materials Co., Ltd to Report Fiscal Year 2020 Results on Mar 26, 2021Sobute New Materials Co., Ltd announced that they will report fiscal year 2020 results on Mar 26, 2021Is New 90 Day High Low • Feb 10New 90-day high: CN¥29.24The company is up 4.0% from its price of CN¥28.25 on 12 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥162 per share.Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.8x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 104%.Is New 90 Day High Low • Dec 17New 90-day low: CN¥23.90The company is down 26% from its price of CN¥32.12 on 18 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥161 per share.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥405.9m, up 37% from the prior year. Total revenue was CN¥3.46b over the last 12 months, up 14% from the prior year.Is New 90 Day High Low • Oct 24New 90-day low: CN¥26.52The company is down 3.0% from its price of CN¥27.45 on 24 July 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥87.07 per share.공시 • Jul 08Sobute New Materials Co., Ltd to Report First Half, 2020 Results on Aug 18, 2020Sobute New Materials Co., Ltd announced that they will report first half, 2020 results on Aug 18, 2020이익 및 매출 성장 예측SHSE:603916 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20285,617279N/A493112/31/20274,849219N/A359112/31/20264,140162N/A30613/31/20263,570127273432N/A12/31/20253,556121164371N/A9/30/20253,657111342545N/A6/30/20253,665106214474N/A3/31/20253,65899349632N/A12/31/20243,55596334581N/A9/30/20243,48298125423N/A6/30/20243,485117338606N/A3/31/20243,495141-6294N/A12/31/20233,58216032370N/A9/30/20233,576194119437N/A6/30/20233,626221-126212N/A3/31/20233,66424837381N/A12/31/20223,715288-78219N/A9/30/20224,004401-136169N/A6/30/20224,224481-3311N/A3/31/20224,466535-43242N/A12/31/20214,52253339336N/A9/30/20214,434505-279168N/A6/30/20214,268490-260130N/A3/31/20213,999470-41336N/A12/31/20203,652441-14333N/A9/30/20203,456406273482N/A6/30/20203,348387215396N/A3/31/20203,264355260432N/A12/31/20193,307354N/A419N/A9/30/20193,017297N/A144N/A6/30/20192,750228N/A3N/A3/31/20192,427287N/A-13N/A12/31/20182,316268N/A-98N/A9/30/20182,100241N/A-255N/A6/30/20181,912239N/A-157N/A3/31/20181,773129N/A-185N/A12/31/20171,680134N/A-121N/A9/30/20171,553154N/A161N/A6/30/20171,450147N/A179N/A3/31/20171,284140N/A169N/A12/31/20161,314133N/A155N/A6/30/20161,259145N/A50N/A3/31/20161,287158N/A63N/A12/31/20151,314171N/A75N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 603916 의 연간 예상 수익 증가율(28.3%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 603916 의 연간 수익(28.3%)이 CN 시장(27.2%)보다 빠르게 성장할 것으로 예상됩니다.고성장 수익: 603916 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.수익 대 시장: 603916 의 수익(연간 16.3%)이 CN 시장(연간 16.2%)보다 빠르게 성장할 것으로 예상됩니다.고성장 매출: 603916 의 수익(연간 16.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 603916의 자본 수익률은 3년 후 5.8%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 11:47종가2026/05/22 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Sobute New Materials Co., Ltd는 5명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Maoda YangChina International Capital Corporation LimitedWei LiuHaitong International Research LimitedYanhe FangHuatai Research2명의 분석가 더 보기
Price Target Changed • Apr 18Price target decreased by 12% to CN¥10.83Down from CN¥12.31, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥10.61. Stock is up 47% over the past year. The company is forecast to post earnings per share of CN¥0.38 for next year compared to CN¥0.29 last year.
Major Estimate Revision • May 05Consensus EPS estimates fall by 15%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥3.63b to CN¥3.77b. EPS estimate fell from CN¥0.408 to CN¥0.347 per share. Net income forecast to grow 56% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥9.67 unchanged from last update. Share price rose 10.0% to CN¥8.16 over the past week.
Price Target Changed • Sep 03Price target decreased by 9.6% to CN¥8.91Down from CN¥9.86, the current price target is an average from 4 analysts. New target price is 27% above last closing price of CN¥7.04. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥0.36 for next year compared to CN¥0.38 last year.
Major Estimate Revision • Sep 02Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.71b to CN¥3.54b. EPS estimate also fell from CN¥0.462 per share to CN¥0.392 per share. Net income forecast to grow 59% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥9.86 to CN¥9.24. Share price rose 2.8% to CN¥7.36 over the past week.
분석 기사 • Aug 28Earnings Release: Here's Why Analysts Cut Their Sobute New Materials Co., Ltd (SHSE:603916) Price Target To CN¥9.24As you might know, Sobute New Materials Co., Ltd ( SHSE:603916 ) recently reported its quarterly numbers. Results look...
분석 기사 • Apr 29Earnings Update: Sobute New Materials Co., Ltd (SHSE:603916) Just Reported And Analysts Are Trimming Their ForecastsShareholders might have noticed that Sobute New Materials Co., Ltd ( SHSE:603916 ) filed its first-quarter result this...
Valuation Update With 7 Day Price Move • May 12Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥14.46, the stock trades at a forward P/E ratio of 35x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 4.5% over the past three years.
Price Target Changed • Apr 18Price target decreased by 12% to CN¥10.83Down from CN¥12.31, the current price target is an average from 2 analysts. New target price is approximately in line with last closing price of CN¥10.61. Stock is up 47% over the past year. The company is forecast to post earnings per share of CN¥0.38 for next year compared to CN¥0.29 last year.
Reported Earnings • Apr 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.29 (up from CN¥0.23 in FY 2024). Revenue: CN¥3.56b (flat on FY 2024). Net income: CN¥121.0m (up 26% from FY 2024). Profit margin: 3.4% (up from 2.7% in FY 2024). Revenue missed analyst estimates by 7.6%. Earnings per share (EPS) also missed analyst estimates by 19%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
공시 • Apr 16Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026Sobute New Materials Co., Ltd, Annual General Meeting, May 12, 2026, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
New Risk • Apr 16New major risk - Revenue and earnings growthEarnings have declined by 38% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 38% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.6% average weekly change).
공시 • Mar 30Sobute New Materials Co., Ltd to Report Q1, 2026 Results on Apr 28, 2026Sobute New Materials Co., Ltd announced that they will report Q1, 2026 results on Apr 28, 2026
New Risk • Feb 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.6% average weekly change).
Buy Or Sell Opportunity • Jan 30Now 26% undervaluedOver the last 90 days, the stock has risen 28% to CN¥13.20. The fair value is estimated to be CN¥17.75, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 48%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 130% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥12.48, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 28x in the Chemicals industry in China. Total loss to shareholders of 17% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.06 per share.
Valuation Update With 7 Day Price Move • Jan 09Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥11.25, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 26x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥16.84 per share.
공시 • Dec 26Sobute New Materials Co., Ltd to Report Fiscal Year 2025 Results on Apr 16, 2026Sobute New Materials Co., Ltd announced that they will report fiscal year 2025 results on Apr 16, 2026
Reported Earnings • Oct 29Third quarter 2025 earnings released: EPS: CN¥0.07 (vs CN¥0.06 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.07 (up from CN¥0.06 in 3Q 2024). Revenue: CN¥904.0m (flat on 3Q 2024). Net income: CN¥30.9m (up 22% from 3Q 2024). Profit margin: 3.4% (up from 2.8% in 3Q 2024). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
Board Change • Oct 11Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Qijun Yu was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2025 Results on Oct 29, 2025Sobute New Materials Co., Ltd announced that they will report Q3, 2025 results on Oct 29, 2025
New Risk • Jul 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (2.7% net profit margin).
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥11.56, the stock trades at a forward P/E ratio of 30x. Average forward P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 41% over the past three years.
공시 • Jun 30Sobute New Materials Co., Ltd to Report First Half, 2025 Results on Aug 29, 2025Sobute New Materials Co., Ltd announced that they will report first half, 2025 results on Aug 29, 2025
Declared Dividend • Jun 07Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 33% lower than last year. Ex-date: 12th June 2025 Payment date: 12th June 2025 Dividend yield will be 1.1%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (42% earnings payout ratio) and cash flows (12% cash payout ratio). The dividend has decreased over the past 76 years, indicating a lack of growth and stability in payments. EPS is expected to grow by 146% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Major Estimate Revision • May 05Consensus EPS estimates fall by 15%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from CN¥3.63b to CN¥3.77b. EPS estimate fell from CN¥0.408 to CN¥0.347 per share. Net income forecast to grow 56% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target of CN¥9.67 unchanged from last update. Share price rose 10.0% to CN¥8.16 over the past week.
Reported Earnings • Apr 29Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: CN¥0.23 (down from CN¥0.38 in FY 2023). Revenue: CN¥3.56b (flat on FY 2023). Net income: CN¥95.9m (down 40% from FY 2023). Profit margin: 2.7% (down from 4.5% in FY 2023). Revenue exceeded analyst estimates by 3.9%. Earnings per share (EPS) missed analyst estimates by 35%. Revenue is forecast to grow 7.2% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.
공시 • Apr 29Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025Sobute New Materials Co., Ltd, Annual General Meeting, May 20, 2025, at 09:30 China Standard Time.
공시 • Mar 28Sobute New Materials Co., Ltd to Report Q1, 2025 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report Q1, 2025 results on Apr 29, 2025
공시 • Dec 27Sobute New Materials Co., Ltd to Report Fiscal Year 2024 Results on Apr 29, 2025Sobute New Materials Co., Ltd announced that they will report fiscal year 2024 results on Apr 29, 2025
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.11 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.06 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥912.4m (flat on 3Q 2023). Net income: CN¥25.3m (down 43% from 3Q 2023). Profit margin: 2.8% (down from 4.9% in 3Q 2023). Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 23% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Sobute New Materials Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024Sobute New Materials Co., Ltd announced that they will report Q3, 2024 results on Oct 26, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥7.57, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
분석 기사 • Sep 26Sobute New Materials Co., Ltd's (SHSE:603916) Shares Not Telling The Full StoryIt's not a stretch to say that Sobute New Materials Co., Ltd's ( SHSE:603916 ) price-to-earnings (or "P/E") ratio of...
Price Target Changed • Sep 03Price target decreased by 9.6% to CN¥8.91Down from CN¥9.86, the current price target is an average from 4 analysts. New target price is 27% above last closing price of CN¥7.04. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥0.36 for next year compared to CN¥0.38 last year.
Major Estimate Revision • Sep 02Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.71b to CN¥3.54b. EPS estimate also fell from CN¥0.462 per share to CN¥0.392 per share. Net income forecast to grow 59% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target down from CN¥9.86 to CN¥9.24. Share price rose 2.8% to CN¥7.36 over the past week.
분석 기사 • Aug 28Earnings Release: Here's Why Analysts Cut Their Sobute New Materials Co., Ltd (SHSE:603916) Price Target To CN¥9.24As you might know, Sobute New Materials Co., Ltd ( SHSE:603916 ) recently reported its quarterly numbers. Results look...
Reported Earnings • Aug 27Second quarter 2024 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.069 (down from CN¥0.13 in 2Q 2023). Revenue: CN¥984.5m (down 1.0% from 2Q 2023). Net income: CN¥32.2m (down 43% from 2Q 2023). Profit margin: 3.3% (down from 5.7% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has only fallen by 30% per year, which means it has not declined as severely as earnings.
분석 기사 • Aug 14Sobute New Materials (SHSE:603916) Might Be Having Difficulty Using Its Capital EffectivelyIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
공시 • Jun 28Sobute New Materials Co., Ltd to Report First Half, 2024 Results on Aug 27, 2024Sobute New Materials Co., Ltd announced that they will report first half, 2024 results on Aug 27, 2024
분석 기사 • Jun 19Sobute New Materials Co., Ltd (SHSE:603916) Stock's 25% Dive Might Signal An Opportunity But It Requires Some ScrutinySobute New Materials Co., Ltd ( SHSE:603916 ) shares have had a horrible month, losing 25% after a relatively good...
Valuation Update With 7 Day Price Move • May 20Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥9.48, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 56% over the past three years.
분석 기사 • Apr 29Earnings Update: Sobute New Materials Co., Ltd (SHSE:603916) Just Reported And Analysts Are Trimming Their ForecastsShareholders might have noticed that Sobute New Materials Co., Ltd ( SHSE:603916 ) filed its first-quarter result this...
공시 • Apr 28Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024Sobute New Materials Co., Ltd, Annual General Meeting, May 28, 2024, at 09:30 China Standard Time. Location: The Company's Meeting Room, Nanjing, Jiangsu China
Reported Earnings • Apr 27First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.10 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.05 (down from CN¥0.10 in 1Q 2023). Revenue: CN¥578.6m (down 13% from 1Q 2023). Net income: CN¥21.1m (down 48% from 1Q 2023). Profit margin: 3.6% (down from 6.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 32% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥7.40, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 68% over the past three years.
공시 • Mar 29Sobute New Materials Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥7.94, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 62% over the past three years.
New Risk • Jan 19New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (109% cash payout ratio). Profit margins are more than 30% lower than last year (5.4% net profit margin). Shareholders have been diluted in the past year (3.0% increase in shares outstanding).
공시 • Dec 30Sobute New Materials Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024Sobute New Materials Co., Ltd announced that they will report fiscal year 2023 results on Apr 26, 2024
Major Estimate Revision • Nov 02Consensus EPS estimates fall by 11%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥3.71b to CN¥3.58b. EPS estimate also fell from CN¥0.63 per share to CN¥0.562 per share. Net income forecast to grow 60% next year vs 66% growth forecast for Chemicals industry in China. Consensus price target down from CN¥16.58 to CN¥15.16. Share price rose 4.2% to CN¥11.75 over the past week.
Price Target Changed • Oct 29Price target decreased by 8.5% to CN¥15.16Down from CN¥16.58, the current price target is an average from 5 analysts. New target price is 29% above last closing price of CN¥11.74. Stock is down 22% over the past year. The company is forecast to post earnings per share of CN¥0.56 for next year compared to CN¥0.69 last year.
Reported Earnings • Oct 27Third quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.17 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.11 (down from CN¥0.17 in 3Q 2022). Revenue: CN¥915.6m (down 5.1% from 3Q 2022). Net income: CN¥44.5m (down 38% from 3Q 2022). Profit margin: 4.9% (down from 7.4% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 26Second quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.13 (down from CN¥0.20 in 2Q 2022). Revenue: CN¥994.9m (down 3.7% from 2Q 2022). Net income: CN¥56.6m (down 33% from 2Q 2022). Profit margin: 5.7% (down from 8.1% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 25% per year, which means it is performing significantly worse than earnings.
Major Estimate Revision • Apr 27Consensus revenue estimates decrease by 10%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.71b to CN¥4.23b. EPS estimate unchanged from CN¥1.14 per share at last update. Chemicals industry in China expected to see average net income growth of 43% next year. Consensus price target of CN¥20.10 unchanged from last update. Share price fell 6.0% to CN¥14.45 over the past week.
Reported Earnings • Apr 23Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.69 (down from CN¥1.27 in FY 2021). Revenue: CN¥3.71b (down 18% from FY 2021). Net income: CN¥287.9m (down 46% from FY 2021). Profit margin: 7.8% (down from 12% in FY 2021). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.0%. Earnings per share (EPS) also missed analyst estimates by 27%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has fallen by 9% per year, which means it is performing significantly worse than earnings.
Major Estimate Revision • Apr 21Consensus revenue estimates decrease by 10%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.71b to CN¥4.23b. EPS estimate unchanged from CN¥1.05 per share at last update. Chemicals industry in China expected to see average net income growth of 38% next year. Consensus price target of CN¥20.10 unchanged from last update. Share price fell 7.1% to CN¥15.02 over the past week.
Valuation Update With 7 Day Price Move • Nov 29Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.41, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 61% over the past three years.
Board Change • Nov 16Less than half of directors are independentThere are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 2 experienced directors. No highly experienced directors. 2 independent directors (3 non-independent directors). Employees Representative Member of the Supervisory Board Hua Li is the most experienced director on the board, commencing their role in 2021. Independent Director Lily Li was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors.
Price Target Changed • Nov 05Price target decreased to CN¥21.44Down from CN¥24.74, the current price target is an average from 3 analysts. New target price is 36% above last closing price of CN¥15.78. Stock is down 7.6% over the past year. The company is forecast to post earnings per share of CN¥1.14 for next year compared to CN¥1.27 last year.
Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.36 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.36 in 3Q 2021). Revenue: CN¥965.3m (down 19% from 3Q 2021). Net income: CN¥71.4m (down 53% from 3Q 2021). Profit margin: 7.4% (down from 13% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 10% per year.
Major Estimate Revision • Sep 02Consensus revenue estimates fall by 10%The consensus outlook for revenues in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥5.28b to CN¥4.74b. EPS estimate fell from CN¥1.51 to CN¥1.36 per share. Net income forecast to grow 33% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥28.95 to CN¥25.89. Share price fell 7.0% to CN¥18.57 over the past week.
Price Target Changed • Aug 30Price target decreased to CN¥25.89Down from CN¥28.95, the current price target is an average from 5 analysts. New target price is 33% above last closing price of CN¥19.45. Stock is down 13% over the past year. The company is forecast to post earnings per share of CN¥1.41 for next year compared to CN¥1.27 last year.
Reported Earnings • Aug 29Second quarter 2022 earnings released: EPS: CN¥0.20 (vs CN¥0.33 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.20 (down from CN¥0.33 in 2Q 2021). Revenue: CN¥1.03b (down 19% from 2Q 2021). Net income: CN¥83.9m (down 39% from 2Q 2021). Profit margin: 8.1% (down from 11% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the next year, revenue is forecast to grow 38%, compared to a 40% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • May 01Price target decreased to CN¥28.95Down from CN¥31.60, the current price target is an average from 6 analysts. New target price is 28% above last closing price of CN¥22.66. Stock is down 9.8% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.27 last year.
Reported Earnings • Apr 30First quarter 2022 earnings: EPS misses analyst expectationsFirst quarter 2022 results: EPS: CN¥0.19 (up from CN¥0.18 in 1Q 2021). Revenue: CN¥716.2m (down 7.3% from 1Q 2021). Net income: CN¥80.2m (up 2.8% from 1Q 2021). Profit margin: 11% (up from 10% in 1Q 2021). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.5%. Over the next year, revenue is forecast to grow 27%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth.
Major Estimate Revision • Apr 27Consensus EPS estimates fall by 10%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥5.64b to CN¥5.37b. EPS estimate also fell from CN¥1.71 per share to CN¥1.53 per share. Net income forecast to grow 21% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target down from CN¥31.60 to CN¥30.75. Share price fell 3.7% to CN¥21.26 over the past week.
Reported Earnings • Apr 17Full year 2021 earnings: EPS misses analyst expectationsFull year 2021 results: EPS: CN¥1.27 (up from CN¥1.16 in FY 2020). Revenue: CN¥4.52b (up 24% from FY 2020). Net income: CN¥532.8m (up 21% from FY 2020). Profit margin: 12% (in line with FY 2020). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.5%. Over the next year, revenue is forecast to grow 25%, compared to a 50% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 23% per year.
Price Target Changed • Jan 06Price target increased to CN¥31.60Up from CN¥26.65, the current price target is an average from 5 analysts. New target price is 19% above last closing price of CN¥26.46. Stock is up 23% over the past year. The company is forecast to post earnings per share of CN¥1.32 for next year compared to CN¥1.16 last year.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥25.19, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 181% over the past three years.
Price Target Changed • Dec 04Price target decreased to CN¥24.31Down from CN¥26.65, the current price target is an average from 5 analysts. New target price is 19% above last closing price of CN¥20.45. Stock is down 3.5% over the past year. The company is forecast to post earnings per share of CN¥1.32 for next year compared to CN¥1.16 last year.
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥21.95, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 136% over the past three years.
Price Target Changed • Nov 01Price target decreased to CN¥26.65Down from CN¥29.61, the current price target is an average from 6 analysts. New target price is 54% above last closing price of CN¥17.32. Stock is down 18% over the past year. The company is forecast to post earnings per share of CN¥1.35 for next year compared to CN¥1.16 last year.
Reported Earnings • Oct 31Third quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.36 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.19b (up 16% from 3Q 2020). Net income: CN¥151.0m (up 11% from 3Q 2020). Profit margin: 13% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 20% per year.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.32 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.27b (up 27% from 2Q 2020). Net income: CN¥137.8m (up 17% from 2Q 2020). Profit margin: 11% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 23% per year.
Reported Earnings • Apr 26First quarter 2021 earnings released: EPS CN¥0.22 (vs CN¥0.16 in 1Q 2020)The company reported a solid first quarter result with improved earnings and revenues, although profit margins were weaker. First quarter 2021 results: Revenue: CN¥772.4m (up 82% from 1Q 2020). Net income: CN¥78.1m (up 58% from 1Q 2020). Profit margin: 10% (down from 12% in 1Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 28% per year.
Reported Earnings • Mar 27Full year 2020 earnings released: EPS CN¥1.39 (vs CN¥1.14 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.65b (up 11% from FY 2019). Net income: CN¥440.8m (up 24% from FY 2019). Profit margin: 12% (up from 11% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year whereas the company’s share price has increased by 24% per year.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥30.84, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 127% over the past three years.
공시 • Mar 04Sobute New Materials Co., Ltd to Report Fiscal Year 2020 Results on Mar 26, 2021Sobute New Materials Co., Ltd announced that they will report fiscal year 2020 results on Mar 26, 2021
Is New 90 Day High Low • Feb 10New 90-day high: CN¥29.24The company is up 4.0% from its price of CN¥28.25 on 12 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥162 per share.
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥27.30, the stock is trading at a trailing P/E ratio of 21x, up from the previous P/E ratio of 17.8x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 104%.
Is New 90 Day High Low • Dec 17New 90-day low: CN¥23.90The company is down 26% from its price of CN¥32.12 on 18 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥161 per share.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥405.9m, up 37% from the prior year. Total revenue was CN¥3.46b over the last 12 months, up 14% from the prior year.
Is New 90 Day High Low • Oct 24New 90-day low: CN¥26.52The company is down 3.0% from its price of CN¥27.45 on 24 July 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥87.07 per share.
공시 • Jul 08Sobute New Materials Co., Ltd to Report First Half, 2020 Results on Aug 18, 2020Sobute New Materials Co., Ltd announced that they will report first half, 2020 results on Aug 18, 2020